Brightseed, which is pioneering biosciences and artificial intelligence, has formed a “Bioactives Coalition” to advance education and advocacy of science-backed bioactive compounds among food and health industries, consumers, and policymakers.

The announcement comes ahead of the American Society for Nutrition’s (ASN) annual conference “Nutrition 2023” (July 22-25 in Boston, MA) where Brightseed will host a satellite symposium on July 23: The Scientific Evolution of Bioactives in Human Health, Current Challenges, and the Path Ahead Illuminated by AI-Driven Science.

“Given the advancement in science and technology, the time is ripe to help build a widely accepted consensus on the definition and role of bioactive compounds for integration into dietary guidelines or current regulatory frameworks,” said Jan-Willem Van Klinken, Brightseed’s SVP of scientific and medical affairs. “Bioactives are the ‘missing good’ in our food system and a core component required for proactive and preventative health. With the tools and research momentum available today, we can go beyond vitamins, minerals, and proteins and begin including bioactives as an important part of nutrition and in modern medical education.”

The Bioactives Coalition is intended to facilitate interactions among food and health system leaders who champion the adoption of bioactive compounds into U.S. dietary guidelines. The coalition also aims to educate on the mounting scientific evidence, advancements in research and discovery, and key perspectives to inform bioactive use and regulation in functional food, beverage, and supplements.

Bioactives Coalition members include researchers and experts working at the intersection of agriculture, food and health:

• Jed W. Fahey M.S., Sc.D – Johns Hopkins nutritional biochemist whose research on plant-based nutrition targets chronic disease prevention;
• Mark Hyman, MD – Founder and Senior Advisor for the Cleveland Clinic Center for Functional Medicine; founder and director of The UltraWellness Center; host of The Doctor’s Farmacy Podcast;
• Taylor C. Wallace, PhD, CFS, FACN – Principal and CEO of the Think Healthy Group; co-author of the first North American guideline and intake recommendation for flavan-3-ols;
• Katie Stebbins – Executive Director of The Food & Nutrition Innovation Institute at Tufts University;
• Ashlie Burkart, MD, CM – Chief Scientific Officer at Germin8 Ventures; Associate with the Belfer Center’s Environment and Natural Resources Program, Harvard Kennedy School;
• Chef Robert E. Graham, MD, MPH – Harvard-trained researcher and physician, public health scientist, food activist and founder of FRESH Medicine and FRESH Med U; and
• Jennifer Kelly, PhD – Nutrition Director at Food Systems For The Future.

In 2022, the Academy of Nutrition and Dietetics led the development of the first ever North American guideline and daily intake recommendation for flavan-3-ols, a watershed moment for
the recognition of bioactives which outlines 400-600 mg per day recommendation from foods such as tea, berries, cocoa, apples, pears and cinnamon. The paper, co-authored by coalition member Dr. Taylor Wallace, serves as a substantial framework in which future bioactives recommendations can be considered, as artificial intelligence is accelerating new health insights and expanding bioactive sources at a quickened pace.